Newsfeeds - Spark Newswire

1 minute read

Champions Oncology Q3 EPS $(0.16) Misses $(0.03) Estimate, Sales $12.77M Miss $13.13M Estimate

March 15, 3:57 PM

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.03) by 433.33 percent. This is a 328.57 percent decrease over earnings of $0.07 per share

CSBR

2 minute read

Analyzing Champions Oncology’s Short Interest

By Benzinga Insights

December 15, 2:14 PM

Champions Oncology's (NASDAQ:CSBR) short percent of float has risen 6.9% since its last report. The company recently reported that it has 64 thousand shares sold short, which is 0.93% of all regular shares that are available for trading.

CSBR

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

December 14, 5:31 PM

Gainers PLx Pharma (NASDAQ:PLXP) stock increased by 10.6% to $0.23 during Wednesday’s after-market session. The market value of…

CLVS

7 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

November 10, 12:29 PM

During Thursday's session, 97 companies made new 52-week lows.

ACST

6 minute read

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday

By Lisa Levin

September 16, 4:38 AM

Gainers

ADBE

1 minute read

Earnings

Earnings Preview For Champions Oncology

By Benzinga Insights

September 7, 10:10 AM

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that Champions Oncology will report an earnings per share (EPS) of $0.01.

CSBR

6 minute read

Earnings Scheduled For July 21, 2022

By Benzinga Insights

July 21, 4:41 AM

Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.

AAL

1 minute read

Earnings

A Preview Of Champions Oncology’s Earnings

By Benzinga Insights

July 20, 2:05 PM

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that Champions Oncology will report an earnings per share (EPS) of $0.02.

CSBR

2 minute read

Earnings

Champions Oncology Earnings Perspective: Return On Capital Employed

By Benzinga Insights

March 16, 11:04 AM

According to Benzinga Pro, during Q3, Champions Oncology (NASDAQ:CSBR) earned $787.00 thousand, a 184.12% increase from the preceding quarter. Champions Oncology also posted a total of $13.19 million in sales, a 11.94% increase since Q2.

CSBR

2 minute read

General
News

Champions Oncology Announces Partnership With Fannin Innovation To Jointly Develop Therapeutic Raptamer Drug Conjugates

By Bill Haddad

January 20, 9:44 AM

Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, announced today a therapeutic

CSBR